NEW YORK - Sally Susman, Pfizer's executive VP and chief corporate affairs officer, will depart the pharmaceutical giant at ...

Susman shared Tuesday that she’ll be stepping down from her role as EVP and chief corporate affairs officer after 18 years with the company. Susman joined Pfizer in 2007 and helped lead the company ...

According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.

Investing.com -- Pfizer Inc. (NYSE:PFE) is undergoing a corporate restructuring that includes the departure of Sally Susman, the company’s chief corporate affairs officer who has managed public ...

DD’s Ortenca Aliaj and the FT’s Jim Pickard first reported on Tuesday that Sunak is set to join Goldman Sachs as a senior adviser, where he’ll work with its executives to advise clients on ...

Additionally, Pfizer is undergoing a corporate restructuring, which includes the departure of Sally Susman, the chief corporate affairs officer.